Abstract: The invention relates to a manufacturing process for the production of a lipid-fiber powder. In particularly the invention relates to a process for the production of a lipid-fiber powder having between 40 to 78 wt % of oil or fat (by weight of total lipid-fiber powder) and 22 to 60 wt % of a vegetable fiber (by weight of total lipid-fiber powder), wherein the fiber is characterized by having a rate of hydration between 15 to 500 cP/min and wherein the oil or fat has a solid fat content (SFC) at 20° C. below 12 wt %.

Abstract: An intelligent shelf comprising: a top platform; an electronics module including: one or more sensors for sensing presence of content on the top platform; a wireless communication chip for enabling data communication over a network; a display screen for displaying dynamic messages based on the data communication and the sensing.

Abstract: A shoulder strap clip for a shoulder bag having a first strap and a second strap. The shoulder strap clip includes a shoulder padding configured to rest on a shoulder of a user; a spring-loaded clip rigidly attached to the shoulder padding at one end and configured to extend over a top surface of the shoulder padding. The spring-loaded clip includes a first contoured slot configured to receive the first strap of the shoulder bag; and a second contoured slot configured to receive the second strap of the shoulder bag.

Abstract: The use of a bacterial secondary metabolite, thaxtomin is described as an effective herbicide on broadleaved, sedge and grass weeds, e.g., in rice fields with no phytotoxicity to rice as well as on aquatic based weeds.

Abstract: The present invention relates to a process for the synthesis of polyhydroxyalkanoates (PHAs) and PHAs obtained by the said process and the use of the said PHAs. The PHAs of the present invention, called PHACOS, have a novel monomeric composition, as they contain monomers with thioester groups in the side chain that confer new physicochemical properties and allow subsequent chemical modification.

Abstract: A nematicidal product for the biological control of plant pathogenic nematodes containing three new isolates of Bacillus thuringiensis strain N11, Bacillus mojavensis strain SR11 and Azospirillum brasilense strain ALo1, deposited in the Spanish Type Culture Collection (CECT) with the names CECT-7665, CECT-7666 and CECT-5856 respectively, which have a high antagonistic capacity against pathogens of this type, as well as the property of stimulating plant growth through different mechanisms. Liquid and solid formulations of the product which have good stability at room temperature and which are effective in the biological control of plant pathogenic nematodes and for stimulating the growth of plants.

Abstract: The invention relates to a new fungicide product for the biological control of phytopathogenic fungi, which contains a new isolate of Bacillus velezensis strain AH2, deposited in the Spanish Type Culture Collection (CECT) as CECT-7221, which has a high antagonist activity against this type of pathogen, as well as the property of stimulating plant growth by different mechanisms. The invention also relates to a liquid formulation which has good stability at ambient temperature and is effective in the treatment of diseases caused by phytopathogenic fungi and for the stimulation of plant growth.

Abstract: A biological fertilizer and plant growth stimulator including: a. a pure culture of strain C3 of the Pantoea dispersa species deposited in the Spanish Type Culture Collection (CECT) with CECT number 5801, b. a pure culture of strain M3 of the Azospirillum brasilense species deposited in the CECT with CECT number 5802, both immobilized in a solid support acting as a slow release system, and c. indole-3-acetic acid, and a method for preparing the biological fertilizer and the use thereof as a plant growth stimulator.

Abstract: It relates to the treatment or prevention of a chronic viral infection with a Thymic Stromal Lymphopoietin (TSLP) antagonist thereby avoiding immune evasion and persistence of the virus. It also provides a method of prognosing the evolution of a cervical dysplasia by TSLP expression in a sample of said cervical dysplasia.

Abstract: The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment of oxidative stress-induced diseases or conditions, especially neurodegenerative diseases, such as Alzheimer's Disease and Parkinson's Disease.

Abstract: The invention relates to a novel biological fertiliser, a method for obtaining same and the use thereof as a plant growth stimulator, said fertiliser comprising a pure culture of strain C3 of Pantie dispersal, a pure culture of strain M3 of Azospirillum brasilense and indole-3 acetic acid, all of which are immobilised in a single solid medium acting as a slow release system. The method includes the following main steps: culture of the microorganisms; immobilisation of the cells, nutrients and other substances in the medium; and a single fluid bed drying step which enables lower temperatures to be used and lower moisture contents to be obtained, thereby providing the fertiliser with greater stability. The action of the fertiliser commences upon contact with the plant.

Abstract: The use of a bacterial secondary metabolite, thaxtomin is described as an effective herbicide on broadleaved, sedge and grass weeds, e.g., in rice fields with no phytotoxicity to rice as well as on aquatic based weeds.

Abstract: The invention relates to a new fungicide product for the biological control of phytopathogenic fungi, which contains a new isolate of Bacillus velezensis strain AH2, deposited in the Spanish Type Culture Collection (CECT) as CECT-7221, which has a high antagonist activity against this type of pathogen, as well as the property of stimulating plant growth by different mechanisms. The invention also relates to a liquid formulation which has good stability at ambient temperature and is effective in the treatment of diseases caused by phytopathogenic fungi and for the stimulation of plant growth.

Abstract: The invention relates to a method for determining mastitis resistance in bovine subjects, wherein mastitis resistance comprise resistance to both sub-clinical and clinical mastitis. In particular, the method of the invention involves identification of genetic markers and/or Quantitative Trait Locus (QTL) for the determination of mastitis resistance in a bovine subject. The determination of mastitis resistance involves resolution of the specific microsatellite status. Furthermore, the invention relates to a diagnostic kit for detection of genetic marker(s) associated with mastitis resistance. The method and kit of the present invention can be applied for selection of bovine subjects for breeding purposes. Thus, the invention provides a method of genetically selecting bovine subjects with mastitis resistance, thereby yielding cows less prone to mastitis.

Abstract: The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment and/or prevention of oxidative stress-induced diseases or conditions, especially neurodegenerative diseases, such as Alzheimer's Disease and Parkinson's Disease.

Abstract: A microlens chip comprises a variable focus fluidic microlens and actuator. The actuator varies the pressure in a fluidic channel in the microlens chip which is coupled to an aperture opening containing the microlens. Applying an electric field to the actuator creates changes in fluid pressure in the fluidic channel, which in turn changes the radius of curvature (i.e., focal length) of the fluidic microlens.

Abstract: Chemical compounds having structural formula I and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyperproliferative disorders.

Abstract: Q is —N=or CR2 X is S, O or NOR3 Y is —O—, —S—, —SO— or —SO2— R and R1 are each, independently, H, a substituted or unsubstituted aliphatic, aromatic, heteroaromatic or aralkyl group R2 is H or a substituent R3 is H, or —C(O)R4 R4 is a substituted or unsubstituted aliphatic or aromatic group n is an integer from 0 to 1 Chemical compounds having structural formula I and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyperproliferative disorders.

Abstract: The compound referred to herein as IB-962 12, having structure (I) can be obtained by cultivating the strain of Micromonospora sp. ES25-008, available under the accession number CECT-3333, and can be hydrolyzed to give IB-96212B having structure (II). The sugar substituent which is L-rhodinose, can its elf be derivatized or the sugar can be replaced, in either case, giving further derivatives of IB-96212 having a group other than L-rhodinose at the position of the sugar.

Abstract: Certain 1,2,4-triazolo(4,3-b)pyridazines of formula ##STR1## including pharmaceutically acceptable salts thereof, wherein R.sub.1 -R.sub.8 are as defined in the disclosure, for the treatment, prophylaxis and/or inhibition of seizures, neurological disorders such as epilepsy and/or conditions in which there is neurological damage such as stroke, brain trauma, cerebral ischemia, head injuries and hemorrhage are disclosed.